To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 05 June 2017 Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR ...

Case Name: Endo Ventures Unlimited Co. v. Nexus Pharms. Inc., Civ. No. 23-cv-299-BHL, 2024 WL 1254358 (E.D. Wis. Mar. 25, 2024) (Ludwig, J.) Drug Product and Patent(s ...

Endo’s subsidiary Endo Ventures has reached an agreement with Maia Pharmaceuticals to distribute bivalirudin injection in a ready-to-use 250 mg/50 ml single-use vial in the United States.

(RTTNews) - Endo International Plc (ENDP) said Monday that its subsidiary, Endo Ventures Limited, has acquired six development stage, ready-to-use injectable product candidates from Nevakar ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Maureen Coghlan of Archer has entered an appearance for Endo Ventures Ltd., Par Pharmaceutical Inc. and Par Sterile Products LLC in a pending patent lawsuit concerning an ephedrine sulfate IV ...

DUBLIN, Sept. 3, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic ...

ASHBURN, Va., July 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Inc. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases ...

COPENHAGEN, Denmark and DUBLIN, June 6, 2017 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that its U.S. subsidiary, Veloxis Pharmaceuticals, Inc., and Endo Ventures ...